West Pharmaceutical Services Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.4% | -0.6% | +4.3% | -8.3% | -7.7% | +5.7% | +16.9% | +10.4% | +29.2% | +30.5% | +11.7% | +3.0% | +0.4% | +4.6% | +8.0% | +6.2% | +8.1% | +3.9% | -1.5% | +7.8% | +6.0% | +7.4% | +7.3% | +16.4% | +31.9% | +1.9% | +2.3% | -2.0% | +6.3% | |
| – | -4.5% | -2.2% | +2.4% | +0.2% | -3.1% | +7.6% | +10.9% | +11.7% | +35.2% | +28.8% | +11.8% | +2.8% | +0.5% | +4.7% | +8.4% | +2.9% | +6.3% | +4.3% | -3.0% | +6.8% | +7.8% | +7.8% | +5.4% | +11.7% | +20.2% | +5.4% | +4.1% | +4.0% | +4.2% | |
| – | +4.6% | +2.1% | +7.5% | -22.0% | -17.3% | +1.3% | +32.5% | +7.5% | +15.7% | +35.1% | +11.5% | +3.7% | +0.3% | +4.6% | +6.7% | +14.4% | +12.1% | +3.0% | +1.8% | +9.9% | +2.3% | +6.6% | +11.4% | +26.1% | +52.8% | -2.9% | -0.5% | -11.5% | +10.1% | |
| – | – | – | – | – | -7.3% | +20.8% | -13.0% | -66.3% | +25.4% | +40.5% | +45.0% | +16.1% | +6.4% | +20.1% | +21.8% | +14.1% | +14.2% | -1.6% | -8.6% | +7.9% | +6.3% | +3.1% | -3.5% | +20.6% | +12.6% | +10.8% | +16.9% | +1.0% | +7.5% | |
| – | -3.6% | +0.4% | +10.5% | -13.1% | +8.4% | +12.5% | +34.4% | -5.2% | +14.4% | +29.6% | -2.2% | +4.5% | +11.6% | +5.6% | +1.8% | +14.1% | +7.7% | -2.6% | +1.9% | +2.9% | +1.2% | +8.4% | +3.7% | +10.7% | +20.1% | -5.3% | +2.8% | -4.2% | +14.8% | |
| – | -1.4% | +0.7% | +10.5% | -7.8% | -28.5% | +8.1% | +0.5% | +27.3% | +16.4% | +29.4% | +14.5% | -0.4% | +11.0% | +7.1% | +5.4% | +12.6% | +8.6% | -2.5% | +0.4% | +3.6% | +1.8% | +3.5% | +6.9% | +12.0% | +18.9% | -9.5% | +12.4% | -3.4% | +19.2% | |
| – | +16.1% | +4.5% | +2.6% | -46.2% | +15.7% | -35.4% | +104.1% | +17.2% | +14.6% | +44.4% | +6.9% | +10.3% | -14.9% | +0.0% | +9.3% | +17.8% | +19.0% | +12.1% | -29.3% | +53.0% | +16.3% | +11.3% | +16.6% | +41.0% | +81.1% | +0.6% | -6.9% | -16.4% | +3.8% | |
| – | – | – | – | – | – | – | – | – | +65.9% | -9.9% | +14.2% | +10.3% | -5.0% | -10.5% | +10.3% | -3.3% | +4.1% | -13.9% | -3.8% | -44.0% | -7.1% | +24.6% | -1.2% | +6.3% | +0.0% | -10.6% | +15.8% | -67.0% | -79.3% | |
| – | +112.1% | -51.6% | +104.7% | -94.6% | +796.8% | -38.1% | +173.3% | -12.3% | +54.9% | +35.4% | +2.9% | +24.1% | -21.9% | -8.4% | +25.5% | +14.5% | +29.7% | +14.9% | -31.3% | +63.5% | +17.2% | +11.6% | +21.1% | +39.2% | +83.7% | -8.9% | +2.2% | -16.1% | +2.5% | |
| – | +23.1% | +59.4% | -13.2% | -91.8% | +473.3% | -52.3% | +307.3% | -33.5% | -103.6% | – | -30.1% | +37.8% | -43.0% | +0.7% | +72.8% | +39.1% | +22.9% | +17.4% | -44.3% | +106.8% | +48.7% | -48.8% | +42.5% | +22.9% | +47.9% | +7.0% | +6.6% | -12.1% | +13.1% | |
| – | +170.7% | -84.9% | +477.6% | -95.9% | -425.0% | – | +73.4% | -39.2% | +135.1% | +47.1% | +5.4% | +21.6% | -15.6% | -10.1% | +15.6% | +6.9% | +39.2% | +13.2% | -24.8% | +50.2% | +4.9% | +37.3% | +16.8% | +43.2% | +91.2% | -11.5% | +1.3% | -17.0% | +0.2% | |
| – | +11.7% | +3.4% | +5.3% | -25.7% | -1.6% | +10.8% | +2.4% | +11.4% | +30.1% | +22.0% | +5.1% | +18.2% | -10.6% | -3.1% | +13.7% | +9.1% | +23.8% | +9.9% | -19.7% | +31.6% | +13.3% | +8.5% | +14.2% | +28.7% | +69.5% | -8.1% | +4.5% | -11.9% | -2.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.